食道支架市场按产品类型、应用和最终用户划分 - 全球预测 2025-2032

预计到 2032 年，食道支架市场规模将达到 2.6342 亿美元，复合年增长率为 6.47%。

关键市场统计数据
基准年 2024	1.5947亿美元
预计年份：2025年	1.6992亿美元
预测年份 2032	2.6342亿美元
复合年增长率 (%)	6.47%

在器械设计、手术环境和利害关係人决策因素不断创新的背景下，了解食道支架的临床重要性和商业性背景

食道支架已成为阻塞性和穿孔性食道疾病多学科诊疗路径中的治疗方法，根据临床情况，弥合了安宁疗护、根治性治疗和安宁疗护之间的差距。材料科学、输送系统和支架设计的最新创新拓展了临床医生的选择范围，并优化了手术流程。同时，医保报销模式的转变和门诊手术环境的不断发展正在改变医疗服务的提供方式。随着器械的不断更新，从介入性胃肠病学家到医院供应链管理人员等相关人员都面临着临床疗效、手术效率和长期耐用性之间复杂的权衡取舍。

本导言对当前的医疗器材分类、常见临床适应症以及影响采购和应用的宏观经济和监管趋势进行了统一概述。这为深入探讨医疗器材技术的变革性变化、新兴贸易政策的影响、市场区隔主导的商业性意义、区域应用差异、製造商之间的竞争行为以及为领导者提供的实用建议奠定了基础。贯穿始终的重点在于将技术进步转化为营运和策略洞察，以支持实现最佳患者疗效和永续的商业模式。

材料、输送系统、监管重点和治疗部位转变等方面的进步正在重新定义食道支架的临床实践和商业模式。

食道支架领域正经历着一场变革性的转变，这主要得益于技术进步、临床实践的改变以及供应链的现代化。材料工程的进步加速了具有更佳径向力控制和顺应性的自膨胀金属支架的普及应用。同时，生物可降解聚合物的进步为临时支架的建造开闢了新的途径，从而减少了取出支架的必要性。更小巧的输送系统和更清晰的透视成像技术在许多情况下缩短了手术时间，使得更多手术能够从住院手术室转移到门诊手术中心和专科诊所。因此，临床医生能够提供微创治疗方案，并加快患者的康復速度，这正在改变转诊模式和医保支付方的决策。

在医疗器材创新的同时，监管机构对上市后监测和真实世界数据的重视，也促使製造商更加关注长期临床结果和器材註册。医疗系统日益要求透过降低併发症率和再次手术率来体现可衡量的价值，这促使製造商投资于数据基础设施和临床合作。在商业方面，医疗服务提供者与支付方之间日益紧密的整合以及集中化的采购能力，正推动製造商开发全面的服务提案和灵活的合约模式。同时，支持术前规划、术中指导和远距追踪的数位健康工具正逐渐成为兼具临床效用和营运效率的差异化优势，进一步加速了整合式医疗服务模式的转变。

对美国对进口医疗设备组件和成品征收关税在营运、临床准入和采购方面的影响进行全面评估

美国将于2025年实施的新关税引发了一系列营运和战略应对措施，这些措施对食道支架价值链产生了深远影响，从原材料采购到医院采购委员会都受到了波及。关税相关的成本压力促使医疗设备製造商透过审查其采购基础、探索替代材料以及寻求国内供应协议来降低风险。一些公司正在加快与首选合作伙伴的采购整合，以保持价格和前置作业时间的稳定性。另一些公司则在进行渐进式重新设计，以减少对关税敏感型投入品的依赖。

临床医生和医疗系统采购团队正面临一系列后续影响，例如前置作业时间延长和供应商谈判策略调整，这些都影响了库存管理和手术安排。为了确保医疗资源的取得并按计划开展手术，医院正在采取多种策略，包括多供应商合约、策略性库存缓衝以及与临床团队紧密合作，优先将设备分配给重症监护病例。同时，支付方和医院财务负责人正在重新评估手术成本结构和报销假设，更加关注可证实的临床效益和总医疗成本。这些累积的调整凸显了供应链、临床领导和商业团队需要通力合作，在应对不断上涨的进口相关成本和日益严格的监管审查的同时，维持医疗服务的连续性。

细分市场对产品设计、临床选择标准和采购方式的影响源自于产品、应用和最终用户的详细差异。

市场区隔洞察表明，器材策略和商业化必须根据产品设计、临床适应症和终端用户环境量身定制，以最大限度地提高临床适用性和商业性吸引力。从可生物降解平台到塑胶结构再到自膨胀金属支架，各类产品各有其独特的临床优缺点。可生物降解支架非常适合临时支撑场景，避免移位可带来临床效益。同时，聚乙烯和聚氨酯塑胶支架在一些特定细分市场中继续发挥作用，这些市场优先考虑成本、易于部署和特定机械性能。自膨胀金属涂层器械（包括镍钛合金和不銹钢）在贴合性和径向支撑力方面存在差异，这影响了它们在瘻管闭合和恶性狭窄安宁疗护中的选择。而当组织侵入性和长期通畅性是关键的临床考量时，自膨胀非金属涂层器械（同样包括镍钛合金和不銹钢）则非常有效。

以应用为导向的分类进一步明确了临床路径和商业性通讯。良性狭窄（细分为吻合口狭窄、消化道狭窄和放射相关狭窄）需要特别关注长期重塑以及临时支架与永久支架的风险效益比。瘻管和穿孔病例需要快速闭合和高水平的即时径向支撑，以防止污染并促进癒合。同时，恶性狭窄则优先考虑安宁疗护、管腔通畅性和提高生活品质。终端使用者细分突显了手术环境和采购复杂性的差异：门诊手术中心优先考虑效率高、周转率快的器械；私立和公立医院力求平衡广泛的治疗组合和预算週期；专科诊所则倾向于关注特定手术量和临床医生偏好模式。这些相互交织的细分观点综合起来表明，成功的产品策略应将材料科学和设计与特定的临床适应症以及医疗机构的实际情况相结合。

美洲、欧洲、中东和非洲以及亚太地区的区域法规结构、支付方结构和供应链现状将如何影响疫苗的采纳和商业化策略

区域趋势对食道支架的法规结构、报销机制和临床应用模式产生了显着影响，要求製造商和服务提供者在不同地区采取差异化策略。在美洲，临床上对微创介入治疗的重视以及成熟的报销体系，推动了先进自膨式金属支架的应用，并将支架相关疗效数据纳入基本契约谈判。同时，该地区的供应链中断和关税相关的复杂性促使製造商与大型医院系统加强合作，以确保供应的连续性，并使合约条款与手术量相符。

不同的监管法规和医疗保健资金筹措模式正在以不同的方式影响欧洲、中东和非洲的医疗器材应用。在欧洲部分地区，完善的註册登记和卫生技术评估流程推动了临床证据和上市后追踪标准的提高，这有利于那些能够证明长期疗效和成本效益的製造商。在中东和非洲的多个市场，基础设施的限制和集中采购机制影响着医疗设备的组合和定价，这往往为耐用、低成本的解决方案以及包含临床医生培训和支援的伙伴关係创造了机会。在亚太地区，医院容量的快速扩张、手术量的增加以及对国内製造能力的投资正在加速金属和可生物降解平台的应用，而当地的监管路径和伙伴关係通常会影响市场进入的速度和方式。在所有地区，患者人口结构的变化和食道疾​​病发病率的上升支撑着持续的需求，但成功的市场策略需要与当地的临床实践模式、监管预期和采购生态系统进行细緻的调整。

透过材料创新、数据驱动的临床支援以及影响合约授予和临床医生采纳的策略性商业伙伴关係，实现竞争优势。

公司层面的发展趋势正受到产品创新、策略伙伴关係以及对供应链和监管要求的快速反应等因素的共同影响而重塑。领先的製造商正透过投资材料科学、优化镍钛诺和不銹钢合金的製程以实现精确的径向力分布，以及推进用于临时支架的可生物降解聚合物配方，从而实现差异化竞争。此外，一些公司正在拓展其价值提案，不再局限于单纯的器械供应，而是提供培训项目、数位化手术规划工具和基于註册登记的疗效追踪系统，以帮助推动临床应用并与支付方进行价值对话。

竞争定位也体现在不同的市场进入模式。一些公司优先考虑与大型医院系统和综合医疗网络建立直接关係，而其他公司则利用分销管道和区域合作伙伴关係来应对复杂的监管和采购环境。医疗器械製造商与诊断和影像技术提供者之间的策略联盟也在不断增加，这使他们能够提供组合解决方案，从而提高植入精度并缩短手术时间。同时，中型企业和新参与企业通常在利基创新、特定监管辖区的上市速度以及为特定临床领域客製化产品的灵活性方面展开竞争。製造地的选择、供应商多元化以及对品质系统和上市后监管的承诺仍然是影响长期合约可靠性和永续性的决定性因素。

为製造商和医疗系统领导者提供切实可行的优先步骤，以加强证据产生、实现供应链多元化并使商业模式与临床需求保持一致。

为维持成长并保障利润率，产业领导者应采取多管齐下的方法，整合临床证据产生、供应链韧性和灵活的商业性合约。首先，应优先进行强而有力的真实世界证据产生倡议和上市后註册研究，以记录医疗设备在关键适应症（例如吻合口狭窄、消化性溃疡、放射性良性狭窄、恶性阻塞和瘻管治疗）中的表现。这些数据资产将有助于加强与支付方的谈判，并在以疗效指标作为纳入处方笺目录先决条件的地区促进医疗器材的推广应用。其次，应审查筹资策略，以减少对单一国家供应链的依赖，并制定紧急时应对计画，包括合格的替代供应商、区域库存地点以及允许在不影响临床疗效的前提下替换关税敏感组件的设计方案。

第三，我们将提供一系列适用于门诊手术中心、公立和私立医院以及专科诊所的设备和服务组合，并开发满足终端用户需求的商业模式。这些模式包括弹性价格设定、培训和指导方案，以及在适当情况下采用绩效付费的合约。第四，我们将投资临床医生教育和数位化工具，以提高手术效率和定位精度，从而改善临床疗效并向支付方证明其价值。最后，我们将积极与监管机构和卫生技术评估机构合作，协调证据生成计划，并加快在重点地区的市场准入。这些措施的共同实施将使製造商和医疗系统能够适应不断变化的市场环境，满足临床医生的期望，并提供永续的、以患者为中心的医疗服务。

我们采用透明的多来源调查方法，结合临床医生访谈、监管和临床文献审查以及三角供应链分析，以提供检验的策略见解。

本研究采用结构化的调查方法，融合了质性研究、系统性二手分析和严谨的三角验证，以确保结论的可靠性和建议的可操作性。此方法首先进行有针对性的初步研究，包括对介入性胃肠病学家、医院采购人员、临床试验研究人员和高级监管事务负责人进行深度访谈，以了解他们对医疗设备性能、临床工作流程和关键采购问题的真实观点。此外，还透过系统性回顾同行评审的临床文献、监管申报文件、医疗设备标籤和会议报告，补充了这些初步信息，从而梳理出医疗设备类型、材料特性和治疗结果方面的趋势。

资料综合涉及对多个资讯来源进行三角验证，以消除差异并提取一致的主题，同时也要考虑监管要求和采购惯例的区域差异。细分框架已透过临床医生和机构层面的回馈检验了其实际应用价值。供应链分析纳入了公开的贸易数据和检验的供应商资讯披露。限制在于，临床实务存在差异，不断变化的监管指南可能会改变商业环境，而製造商与大型客户之间的合​​约条款并非总是完全透明。研究始终遵循伦理标准，所有结论均基于检验的证据和专家意见，以确保结论的可靠性和可操作性。

领导者必须整合临床、营运和商业性方面的各项要素，才能在不断发展的食道支架领域中保持可持续的竞争优势。

总之，食道支架领域正处于转折点。材料创新、手术转移到低风险医疗中心以及对实际疗效日益增长的期望，正在重塑临床实践和商业策略。能够根据特定临床适应症定制产品设计的製造商——无论是用于选择性良性狭窄的临时性可生物降解支架，还是用于恶性梗阻和瘻管的坚固金属支架——都将更有利于满足临床医生的需求和支付方的审查。同时，供应链的韧性和灵活的商业模式对于确保患者能够获得所需产品，同时应对不断变化的贸易政策和采购压力至关重要。

展望未来，策略重点在于实证实践、临床支援和本地市场适应，这将决定哪些机构能够获得永续的竞争优势。那些在保持灵活的生产和筹资策略的同时，优先考虑医疗设备性能数据与医疗系统价值评估框架之间互通性的相关人员，将更有能力满足不断变化的临床需求和监管要求。最终，在这个领域取得持续成功的关键在于制定一个整合研发、监管、供应链和商业团队的综合计划，以交付能够显着改善患者预后和营运效率的医疗设备。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 可生物降解食道支架在治疗良性食道狭窄的应用日益广泛，并减少了支架取出手术。
• 将先进的药物释放型涂层整合到食道支架上，以最大限度地减少肿瘤渗透并延长通畅性
• 针对复杂解剖结构及个人化治疗，开发患者特异性3D列印食道支架
• 在恶性食道狭窄的安宁疗护中，越来越多地使用全覆膜自膨式金属支架
• 推广微创内视镜支架留置技术，以缩短住院时间和降低併发症发生率
• 为了防止食道支架形成生物膜和阻塞，抗菌奈米涂层的研究正在蓬勃发展。
• 由于人口老化导致巴瑞特氏食道症和食道癌发生率上升，市场需求成长。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 食道支架市场依产品类型划分

• 可生物降解
• 塑胶
  • 聚乙烯
  • 聚氨酯
• 自膨式金属涂层支架
  • 镍钛诺
  • 不銹钢
• 自膨胀金属化
  • 镍钛诺
  • 不銹钢

9. 食道支架市场依应用领域划分

• 良性狭窄
  • 吻合口狭窄
  • 消化性狭窄
  • 放射学狭窄
• 瘻管穿孔
• 恶性狭窄

第十章 食道支架市场（依最终用户划分）

• 门诊手术中心
• 医院
  • 私立医院
  • 公立医院
• 专科诊所

第十一章 食道支架市场（按地区划分）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十二章 食道支架市场（依类别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十三章 各国食道支架市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十四章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Medtronic plc
  • Taewoong Medical Co., Ltd.
  • Micro-Tech Endoscopy Co., Ltd.
  • Merit Medical Systems, Inc.
  • S&G Biotech, Inc.
  • Nanjing MicroPort Medical Company Limited
  • Guangzhou Wisco Medical Instrument Co., Ltd.
  • Well Lead Medical Co., Ltd.

The Esophageal Stents Market is projected to grow by USD 263.42 million at a CAGR of 6.47% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 159.47 million
Estimated Year [2025]	USD 169.92 million
Forecast Year [2032]	USD 263.42 million
CAGR (%)	6.47%

Framing the clinical importance and commercial context of esophageal stents amid innovations in device design, procedural settings, and stakeholder decision drivers

Esophageal stents have become a cornerstone intervention within multidisciplinary care pathways for obstructive and perforative esophageal disease, bridging palliation, definitive management, and temporizing measures depending on clinical context. Recent innovations in materials science, delivery systems, and stent design have expanded clinician choice and refined procedural workflows, while evolving reimbursement models and outpatient procedural settings have shifted how care is delivered. As devices evolve, stakeholders from interventional gastroenterologists to hospital supply chain leaders face complex trade-offs between clinical performance, procedural efficiency, and long-term durability.

This introduction synthesizes current device typologies, common clinical indications, and the macroeconomic and regulatory dynamics that shape procurement and adoption. It sets the stage for a deeper examination of transformative shifts in device technology, the ramifications of emergent trade policies, segmentation-driven commercial implications, regional variation in uptake, competitive behaviors among manufacturers, and pragmatic recommendations for leaders. Throughout, the emphasis is on translating technical developments into operational and strategic insights that support optimal patient outcomes and sustainable commercial models.

How converging advances in materials, delivery systems, regulatory focus, and care-site migration are redefining clinical practice and commercial models for esophageal stents

The landscape for esophageal stents is undergoing transformative shifts driven by technological refinement, clinical practice changes, and supply chain modernization. Advances in material engineering have accelerated the adoption of self-expanding metallic devices with improved radial force control and conformability, and simultaneous progress in biodegradable polymers is creating alternative pathways for temporary scaffolding that reduce the need for device retrieval. Delivery system miniaturization and enhanced fluoroscopic visibility have shortened procedural time in many cases, enabling more procedures to migrate from inpatient operating rooms to ambulatory surgical centers and specialty clinics. Consequently, clinicians can offer less invasive options with faster recovery, which reshapes referral patterns and payer conversations.

Alongside device innovation, regulatory emphasis on post-market surveillance and real-world evidence has heightened manufacturers' focus on longitudinal clinical outcomes and device registries. Health systems increasingly require demonstrable value through measurable reductions in complication rates and reintervention, prompting manufacturers to invest in data infrastructure and clinical partnerships. On the commercial front, consolidation among providers and payers is concentrating purchasing power, encouraging manufacturers to develop bundled-service propositions and flexible contracting models. Meanwhile, digital health tools that support pre-procedural planning, intra-procedural guidance, and remote follow-up are emerging as differentiators that align clinical utility with operational efficiencies, further accelerating the shift toward integrated care delivery models.

Assessment of the comprehensive operational, clinical access, and procurement consequences arising from United States tariff measures on imported medical device components and finished devices

The introduction of new tariff measures in the United States in 2025 has prompted a series of operational and strategic responses across the esophageal stent value chain, with effects felt from raw-material procurement to hospital purchasing committees. Tariff-related cost pressures have encouraged device manufacturers to reassess sourcing footprints and to explore alternative materials or domestic supply agreements to mitigate exposure. In some cases, companies have accelerated consolidation of component sourcing with preferred partners to preserve predictability in price and lead time, while others have pursued incremental redesigns that reduce reliance on tariff-sensitive inputs.

Clinicians and health system procurement teams have experienced downstream impacts through extended lead times and altered vendor negotiations, which in turn influence inventory management and procedural scheduling. To preserve access and keep procedures on schedule, hospitals have adopted a range of strategies including multi-vendor contracting, strategic inventory buffers, and closer collaboration with clinical teams to prioritize device allocation for high-acuity cases. Simultaneously, payers and hospital finance leaders are reassessing procedure cost structures and reimbursement assumptions, leading to renewed emphasis on demonstrable clinical benefit and total cost of care. These cumulative adjustments underscore the need for cross-functional coordination, with supply chain, clinical leadership, and commercial teams working together to maintain continuity of care while navigating elevated import-related costs and heightened regulatory scrutiny.

Segment-specific implications for product design, clinical selection criteria, and procurement approaches derived from detailed product, application, and end-user distinctions

Insight into segmentation reveals that device strategy and commercialization must be finely tailored to product design, clinical indication, and end-user environment to maximize clinical fit and commercial traction. Product type distinctions-ranging from biodegradable platforms to plastic constructs and self-expanding metallic options-carry unique clinical trade-offs. Biodegradable stents are positioned for temporary scaffolding scenarios where avoidance of removal confers clinical advantages, whereas plastic stents such as those constructed from polyethylene or polyurethane continue to serve defined niches where cost, ease of deployment, or specific mechanical properties are prioritized. Self-expanding metallic covered devices, available in nitinol and stainless steel variants, tend to offer differences in conformity and radial force that influence selection for sealing fistulae or palliation of malignant strictures, while self-expanding metallic uncovered versions, also in nitinol and stainless steel, remain relevant when tissue ingrowth and long-term patency considerations dominate clinical decision making.

Application-focused segmentation further clarifies clinical pathways and commercial messaging. Benign strictures-subdivided into anastomotic, peptic, and radiation-related etiologies-require particular attention to long-term remodeling and the risk-benefit profile of temporary versus permanent scaffolds. Fistula and perforation cases demand rapid sealing and high immediate radial support to prevent contamination and facilitate healing, while malignant strictures prioritize palliation, luminal patency, and quality-of-life outcomes. End-user segmentation highlights differences in procedural setting and procurement complexity: ambulatory surgical centers may prioritize devices optimized for efficiency and rapid turnover, hospitals-both private and public-must balance broad therapeutic portfolios and budget cycles, and specialty clinics often focus on niche procedural volumes and clinician preference patterns. Taken together, these intersecting segmentation lenses indicate that successful product strategies are those that align material science and design with specific clinical indications and the operational realities of the deploying institution.

How regional regulatory frameworks, payer structures, and supply chain realities across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and commercialization strategies

Regional dynamics exert a strong influence on regulatory frameworks, reimbursement practices, and clinical adoption patterns for esophageal stents, requiring manufacturers and service providers to adopt regionally differentiated strategies. In the Americas, the clinical emphasis on minimally invasive interventions and mature reimbursement systems has supported the adoption of advanced self-expanding metallic devices and the integration of device-related outcomes data into value-based contracting discussions. Conversely, supply chain disruptions and tariff-related complexities in the region have prompted closer collaboration between manufacturers and large hospital systems to ensure continuity of supply and to align contracting terms with procedural volumes.

Across Europe, the Middle East & Africa, regulatory heterogeneity and variable healthcare funding models shape adoption in distinct ways. In parts of Europe, strong registries and health technology assessment processes raise the bar for clinical evidence and post-market follow-up, favoring manufacturers that can demonstrate longitudinal outcomes and cost-effectiveness. In several Middle Eastern and African markets, infrastructural constraints and centralized procurement mechanisms influence device mix and pricing dynamics, often creating opportunities for durable, lower-cost solutions and for partnerships that include clinician training and support. In the Asia-Pacific region, rapid hospital capacity expansion, increasing procedural volumes, and investments in domestic manufacturing capacity are accelerating uptake of both metallic and biodegradable platforms, with local regulatory pathways and partnerships frequently shaping the speed and nature of market entry. Across all regions, evolving patient demographics and rising incidence of esophageal disease underscore persistent demand, but successful market strategies require nuanced alignment with regional clinical practice patterns, regulatory expectations, and procurement ecosystems.

Competitive differentiation through materials innovation, data-enabled clinical support, and strategic commercial partnerships that influence contract wins and clinician adoption

Company-level dynamics are being reshaped by a combination of product innovation, strategic partnerships, and operational responsiveness to supply chain and regulatory demands. Leading manufacturers are differentiating through investments in material science, optimizing nitinol and stainless steel alloy processes to achieve refined radial force profiles, and advancing biodegradable polymer formulations for temporary stenting applications. In addition, several firms are expanding their value propositions beyond pure device supply by offering training programs, digital procedural planning tools, and registry-based outcome tracking that enhance clinical adoption and support payer conversations on value.

Competitive positioning also reflects different go-to-market models: some companies emphasize direct relationships with large hospital systems and integrated health networks, while others leverage distributor channels and partnerships with local firms to navigate complex regulatory and procurement landscapes. Strategic collaborations between device manufacturers and diagnostic or imaging technology providers are becoming more common, enabling combined offerings that improve placement precision and reduce procedure time. At the same time, mid-sized firms and new entrants often compete on niche innovation, speed to market in specific regulatory jurisdictions, and agility in customizing products for distinct clinical segments. Manufacturing footprint decisions, supplier diversification, and commitment to quality systems and post-market surveillance remain decisive factors affecting credibility and long-term contract viability.

Practical and prioritized steps for manufacturers and health system leaders to strengthen evidence generation, diversify supply chains, and align commercial models with clinical site requirements

Industry leaders should adopt a multi-dimensional approach that integrates clinical evidence generation, supply chain resilience, and commercially flexible contracting to sustain growth and protect margins. First, prioritize robust real-world evidence initiatives and post-market registries that capture device performance across key indications such as anastomotic, peptic, and radiation-related benign strictures, as well as malignant obstruction and fistula management. These data assets will strengthen payer negotiations and facilitate adoption in settings where outcomes measurement is a prerequisite for formulary inclusion. Second, reassess sourcing strategies to reduce exposure to single-country supply chains, and develop contingency plans that include qualified alternative suppliers, localized inventory hubs, and design options that permit substitution of tariff-sensitive components without undermining clinical performance.

Third, tailor commercial models to end-user needs by offering device portfolios and service bundles suited to ambulatory surgical centers, private and public hospitals, and specialty clinics. This includes flexible pricing, training and proctoring packages, and outcome-based contracting where appropriate. Fourth, invest in clinician education and digital tools that enhance procedural efficiency and placement accuracy, thereby improving clinical outcomes and demonstrating value to payers. Finally, engage proactively with regulatory authorities and health technology assessment bodies to align evidence generation plans and to expedite market access in priority geographies. Taken together, these actions will enable manufacturers and health systems to navigate evolving trade environments, meet clinician expectations, and deliver sustainable patient-centered care.

A transparent multi-source methodology combining clinician interviews, regulatory and clinical literature review, and triangulated supply chain analysis to produce validated strategic insights

This research synthesizes a structured methodology that blends primary qualitative insights, systematic secondary analysis, and rigorous triangulation to ensure credible conclusions and actionable recommendations. The approach begins with targeted primary engagements including in-depth interviews with interventional gastroenterologists, hospital procurement leads, clinical trial investigators, and senior regulatory affairs professionals to capture frontline perspectives on device performance, clinical workflows, and procurement imperatives. These primary inputs are complemented by a systematic review of peer-reviewed clinical literature, regulatory filings, device labeling, and conference proceedings to map device typologies, material properties, and outcome trends.

Data synthesis employs triangulation across sources to reconcile differences and to surface consistent themes, with attention to geographic variability in regulatory requirements and procurement practices. Segmentation frameworks are validated against clinician- and institution-level feedback to ensure practical relevance, and supply chain analyses incorporate publicly available trade data and verified supplier disclosures. Limitations are acknowledged: clinical practice variation and evolving regulatory guidance can change the operational landscape, and proprietary contract terms between manufacturers and large customers are not always fully transparent. Throughout, ethical standards for research are observed, and claims are grounded in verified evidence and expert input to support defensible, actionable insights.

Synthesis of clinical, operational, and commercial imperatives that leaders must integrate to secure durable advantage in the evolving esophageal stent landscape

In conclusion, the esophageal stent sector is at an inflection point where material innovation, procedural migration to lower-acuity sites, and heightened expectations for real-world outcomes converge to reshape clinical practice and commercial strategy. Manufacturers that align product design with specific clinical indications-whether temporary biodegradable scaffolding for select benign strictures or robust metallic constructs for malignant obstruction and fistula-will be better positioned to satisfy clinician needs and payer scrutiny. Concurrently, supply chain resilience and adaptive commercial models are critical to navigate trade policy shifts and procurement pressures while preserving access to care.

Looking ahead, strategic emphasis on evidence generation, clinician support, and regional market tailoring will determine which organizations capture sustainable advantage. Stakeholders who prioritize interoperability between device performance data and health system value frameworks, while maintaining flexible manufacturing and sourcing strategies, will be best placed to respond to evolving clinical demands and regulatory expectations. Ultimately, the pathway to durable success in this sector requires integrated planning across R&D, regulatory affairs, supply chain, and commercial teams to deliver devices that demonstrably improve patient outcomes and operational efficiency.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Rising adoption of biodegradable esophageal stents for benign stricture management and reduced removal procedures
• 5.2. Integration of advanced drug-eluting coatings on esophageal stents to minimize tumor ingrowth and prolong patency
• 5.3. Development of patient-specific 3D-printed esophageal stents for complex anatomy and personalized therapy
• 5.4. Increasing use of fully covered self-expanding metal stents in palliative care for malignant esophageal strictures
• 5.5. Expansion of minimally invasive endoscopic stent placement techniques to shorten hospital stays and lower complication rates
• 5.6. Surge in research on antimicrobial nanocoatings for esophageal stents to prevent biofilm formation and occlusion
• 5.7. Market growth driven by rising incidence of Barrett's esophagus and esophageal cancer in aging populations

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Esophageal Stents Market, by Product Type

• 8.1. Biodegradable
• 8.2. Plastic
  • 8.2.1. Polyethylene
  • 8.2.2. Polyurethane
• 8.3. Self Expanding Metallic Covered
  • 8.3.1. Nitinol
  • 8.3.2. Stainless Steel
• 8.4. Self Expanding Metallic Uncovered
  • 8.4.1. Nitinol
  • 8.4.2. Stainless Steel

9. Esophageal Stents Market, by Application

• 9.1. Benign Stricture
  • 9.1.1. Anastomotic Stricture
  • 9.1.2. Peptic Stricture
  • 9.1.3. Radiation Stricture
• 9.2. Fistula Perforation
• 9.3. Malignant Stricture

10. Esophageal Stents Market, by End User

• 10.1. Ambulatory Surgical Center
• 10.2. Hospital
  • 10.2.1. Private Hospital
  • 10.2.2. Public Hospital
• 10.3. Specialty Clinic

11. Esophageal Stents Market, by Region

• 11.1. Americas
  • 11.1.1. North America
  • 11.1.2. Latin America
• 11.2. Europe, Middle East & Africa
  • 11.2.1. Europe
  • 11.2.2. Middle East
  • 11.2.3. Africa
• 11.3. Asia-Pacific

12. Esophageal Stents Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Esophageal Stents Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Analysis
  • 14.3.1. Boston Scientific Corporation
  • 14.3.2. Cook Medical LLC
  • 14.3.3. Medtronic plc
  • 14.3.4. Taewoong Medical Co., Ltd.
  • 14.3.5. Micro-Tech Endoscopy Co., Ltd.
  • 14.3.6. Merit Medical Systems, Inc.
  • 14.3.7. S&G Biotech, Inc.
  • 14.3.8. Nanjing MicroPort Medical Company Limited
  • 14.3.9. Guangzhou Wisco Medical Instrument Co., Ltd.
  • 14.3.10. Well Lead Medical Co., Ltd.

LIST OF FIGURES

• FIGURE 1. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 9. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GCC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. G7 ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. NATO ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. ESOPHAGEAL STENTS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 26. ESOPHAGEAL STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. ESOPHAGEAL STENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 150. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 151. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 152. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 153. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 154. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 155. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 156. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 157. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 158. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 159. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 160. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 161. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 162. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 163. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 164. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 165. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 166. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
• TABLE 167. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 168. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 169. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 170. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 171. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 172. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 173. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 174. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 175. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 176. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 177. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 178. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 179. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 180. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 181. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 182. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 183. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 184. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
• TABLE 185. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 186. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 187. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 188. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 189. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 190. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 191. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 192. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 193. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 194. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 195. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 196. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 197. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 198. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 199. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 200. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 201. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 202. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 215. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 217. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
• TABLE 221. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 222. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 223. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 224. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 225. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 226. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 227. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 228. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 229. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 230. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 231. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 232. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 233. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 234. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 235. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 236. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 237. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 238. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
• TABLE 239. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 240. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 241. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 242. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 243. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 244. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 245. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 246. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 247. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 248. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 249. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 250. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 251. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 252. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 253. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 254. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 255. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 256. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
• TABLE 257. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 258. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 259. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 260. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 261. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 262. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 263. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 264. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 265. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 266. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 267. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 268. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 269. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 270. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 271. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 272. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 273. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 274. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
• TABLE 275. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 276. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 277. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 278. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 279. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 280. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 281. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 282. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 283. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 284. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 285. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 286. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 287. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 288. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 289. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 290. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 291. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 292. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
• TABLE 293. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 294. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 295. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 296. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 297. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 298. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 299. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 300. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 301. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 302. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 303. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 304. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 305. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 306. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 307. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 308. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 309. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 310. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 311. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 312. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
• TABLE 313. GCC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 314. GCC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 315. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 316. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 317. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 318. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 319. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
• TABLE 320. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
• TABLE 321. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
• TABLE 322. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
• TABLE 323. GCC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 324. GCC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 325. GCC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
• TABLE 326. GCC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
• TABLE 327. GCC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 328. GCC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 329. GCC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
• TABLE 330. GCC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032